1. Home
  2. FAF vs LEGN Comparison

FAF vs LEGN Comparison

Compare FAF & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

HOLD

Current Price

$78.17

Market Cap

6.8B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.85

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAF
LEGN
Founded
1889
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.9B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
FAF
LEGN
Price
$78.17
$18.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$82.50
$61.33
AVG Volume (30 Days)
801.5K
2.2M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
3.09%
N/A
EPS Growth
376.19
N/A
EPS
3.33
N/A
Revenue
$7,452,200,000.00
N/A
Revenue This Year
$7.85
$42.68
Revenue Next Year
$5.57
$30.52
P/E Ratio
$23.81
N/A
Revenue Growth
21.61
N/A
52 Week Low
$56.20
$16.24
52 Week High
$79.38
$40.05

Technical Indicators

Market Signals
Indicator
FAF
LEGN
Relative Strength Index (RSI) 72.20 24.50
Support Level $64.75 $17.01
Resistance Level N/A $19.88
Average True Range (ATR) 2.11 1.21
MACD 0.86 -0.53
Stochastic Oscillator 98.49 2.36

Price Performance

Historical Comparison
FAF
LEGN

About FAF First American Corporation (New)

First American Financial Corp is engaged in the business of providing title insurance, settlement services, and other financial services and risk solutions. The group's reportable segments are: Title insurance and services, Home warranty, and Corporate. Maximum revenue is generated from the Title insurance and services segment, which provides title insurance, closing, escrow, and related services domestically and internationally in connection with residential and commercial real estate transactions. This segment also provides solutions to mitigate risk and facilitate real estate transactions, along with offering banking, trust, warehouse lending, mortgage subservicing and wealth management services. The majority of the group's revenue is generated from escrow fees and insurance premiums.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: